Assessing the Direct Costs of Treating Nonvalvular Atrial Fibrillation in the United States

References

Page 1

	Year	Citations
Comorbidity Measures for Use with Administrative Data Anne Elixhauser, Claudia Steiner, D.R. Harris, Medical Care	1998	9.6K
Prevalence of Diagnosed Atrial Fibrillation in Adults Alan S. Go, Elaine M. Hylek, Kathleen A. Phillips, JAMA	2001	6.2K
Prevalence, Age Distribution, and Gender of Patients With Atrial Fibrillation William M. Feinberg Archives of Internal Medicine AgingPreventive CardiologyEpidemiology Of AgingUnited StatesThrombosis	1995	2.2K
Smearing Estimate: A Nonparametric Retransformation Method Naihua Duan Journal of the American Statistical Association Signal ReconstructionNonparametric Retransformation MethodInsurance RegulationsEstimation TheoryNonparametric Estimate	1983	2K
Impact of Atrial Fibrillation on Mortality, Stroke, and Medical Costs Philip A. Wolf, Janet B. Mitchell, Colin S. Baker, Archives of Internal Medicine	1998	694
Cost of an emerging epidemic: an economic analysis of atrial fibrillation in the UK Simon Stewart, Niamh Murphy, Andrew Walker, Heart	2004	586
Secular trends in the prevalence of atrial fibrillation: The Framingham study Philip A. Wolf, Emelia J. Benhamin, Albert J. Belanger, American Heart Journal	1996	447
Nonparametric Statistics for Health Care Research: Statistics for Small Samples and Unusual Distributions Dennis W. Luckey, Marjorie A. Pett Journal of the American Statistical Association ReliabilityHealth Care DeliveryNonparametric StatisticsEngineeringHealth Care Research	1998	394
Cost-effectiveness of Warfarin and Aspirin for Prophylaxis of Stroke in Patients With Nonvalvular Atrial Fibrillation Brian F. Gage JAMA	1995	328
Analysis and implications ASHE-ERIC Higher Education Report Theoretical AnalysisEconomicsCritical TheorySpecial IssueTheory Building	1988	260

Page 1